Positive Association Between Ppard Rs2016520 Polymorphism And Coronary Heart Disease In A Han Chinese Population
H. D. Ye,Y. R. Li,Q. X. Hong,A. N. Zhou,Q. L. Zhao,L. M. Xu,M. Q. Xu,X. T. Xu,L. L. Tang,D. J. Dai,D. J. Jiang,Y. Huang,D. W. Wang,S. W. Duan
DOI: https://doi.org/10.4238/2015.June.11.10
2015-01-01
Genetics and Molecular Research
Abstract:PPARD encodes peroxisome proliferator-activated receptor delta, which has been shown to play an important role in controlling lipid metabolism and atherosclerosis. In this case-control study, we explored the relationship between PPARD rs2016520 polymorphism and coronary heart disease (CHD) in a Han Chinese population. A total of 657 CHD cases and 640 controls were included in the association study. rs2016520 polymorphism genotyping was performed using the melting temperature-shift polymerase chain reaction method. The PPARD rs2016520-G allele reduced CHD risk by 17.9% (chi(2) = 5.061, P = 0.025, OR = 0.821, 95% CI = 0.692-0.975). Furthermore, a significant difference in CHD risk was observed for the PPARD rs2016520 polymorphism in the dominant model (AG + GG vs AA: chi(2) = 4.751, degrees of freedom (df) = 1, P = 0.029, OR = 0.784, 95% CI = 0.6310.976). Analysis by age suggested that the G-allele decreased CHD risk by 14.8% in ages greater than 65 years (chi(2) = 4.446, P = 0.035, OR = 0.852, 95%CI = 0.684-1.060). In contrast, meta-analysis of PPARD rs2016520 among 3732 cases and 5042 controls revealed no association between PPARD rs2016520 and CHD (P = 0.19). We found that the PPARD rs2016520-GG genotype decreased CHD risk in a Han Chinese population. Moreover, we found an association between serum high-density lipoprotein cholesterol level and PPARD rs2016520 in senior individuals aged = 65 years. The meta-analysis revealed no association between PPARD rs2016520 and CHD, suggesting ethnic differences in the association between the PPARD locus and CHD.